T

tirzepatide

Product

by Eli Lilly and Company

Heard in 19 episodes across 16 shows since Jun 2026

Tirzepatide is a prescription medication that activates glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It is used under brand names including Mounjaro for type 2 diabetes and Zepbound for chronic weight management in eligible adults.

Discussed inHealth & Science67%Markets17%Business17%

Episodes

19
across 16 shows

This week

0
episodes on 0 shows

Expert statements

2
1 positive · 1 negative

Share of the conversation

Mentions of tirzepatide per 1,000 mentions of anything, 7-day rolling, across the podcasts PodLume Trends follows.

0.0‰0.03‰0.05‰0.07‰0.1‰Aug 15Sep 6Sep 29Oct 21Nov 12
Show the data
DayShare (7-day)Mentions
Aug 210.03‰1
Aug 250.03‰1
Sep 10.01‰1
Sep 30.04‰3
Sep 170.01‰1
Oct 100.01‰1
Oct 230.01‰1
Oct 290.02‰1
Nov 40.02‰1
Nov 50.02‰1
Nov 90.02‰1
Nov 120.02‰1

The full trend: rank, tone and why it is trending →

Email alert

Email me when tirzepatide comes up on a podcast

One email a week at most, with the new episodes that mention tirzepatide. Free, no account needed, unsubscribe in one click.

What experts have said about tirzepatide

2 statements · 1 positive · 1 negative

  1. Tiwa AdebayoNegativeOct 8, 2026· Stock Movers

    Petrelatide trial results were unfavorable and showed high discontinuation rates

    “Petrelatide, had trial results which haven't been super positive, showing high discontinuation rates”

    Listen at 3:33

    Open the episode · Tesco Climbs, Imperial Brands Rises, Zealand Pharma Slips
  2. Tirzepatide may reduce intraocular pressure.

    “Tirzepatide may reduce eye pressure.”

    Listen at 1:24:37

    Open the episode · #876: Dr. Andrew Huberman — Peptides, Performance, and Protocols

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Episodes

19 episodes featuring tirzepatide, newest first